Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults.
作者信息
Scholand Mary Beth, Wells Athol U
机构信息
University of Utah Health Salt Lake City, Utah.
Royal Brompton Hospital London, United Kingdom.
出版信息
Am J Respir Crit Care Med. 2022 Nov 15;206(10):1296. doi: 10.1164/rccm.202207-1260LE.
Abstract
摘要
相似文献
1
Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults.成人特发性肺纤维化（最新进展）及进行性肺纤维化述评
Am J Respir Crit Care Med. 2022 Nov 15;206(10):1296. doi: 10.1164/rccm.202207-1260LE.
2
Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis.特发性肺纤维化和进行性肺纤维化。
Immunol Allergy Clin North Am. 2023 May;43(2):209-228. doi: 10.1016/j.iac.2023.01.010. Epub 2023 Mar 3.
3
A case of progressive lung fibrosis.进行性肺纤维化 1 例。
Am J Med Sci. 2011 Jun;341(6):428-30. doi: 10.1097/MAJ.0b013e31821a9d52.
4
2022 update on clinical practice guidelines for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis.《特发性肺纤维化和进行性肺纤维化临床实践指南2022年更新》
Lancet Respir Med. 2022 Aug;10(8):729-731. doi: 10.1016/S2213-2600(22)00223-5. Epub 2022 Jun 24.
5
Pharmacological treatment of idiopathic pulmonary fibrosis: an update.特发性肺纤维化的药物治疗：更新。
Drug Discov Today. 2015 May;20(5):514-24. doi: 10.1016/j.drudis.2015.01.001. Epub 2015 Jan 19.
6
Do all patients with idiopathic pulmonary fibrosis warrant a trial of therapeutic intervention? A pro-con perspective.所有特发性肺纤维化患者都需要进行治疗干预试验吗？赞成与反对的观点。
Respirology. 2015 Apr;20(3):389-94. doi: 10.1111/resp.12484. Epub 2015 Feb 26.
7
[Pharmacological treatment of idiopathic pulmonary fibrosis (update) and progressive pulmonary fibrosis - S2k Guideline of the German Respiratory Society].[特发性肺纤维化的药物治疗（更新版）及进行性肺纤维化——德国呼吸学会S2k指南]
Pneumologie. 2023 Feb;77(2):94-119. doi: 10.1055/a-1983-6796. Epub 2023 Feb 15.
8
Update on diagnosis and treatment of idiopathic pulmonary fibrosis.特发性肺纤维化的诊断与治疗进展
J Bras Pneumol. 2015 Sep-Oct;41(5):454-66. doi: 10.1590/S1806-37132015000000152.
9
Serum biomarkers in idiopathic pulmonary fibrosis.特发性肺纤维化中的血清生物标志物
Panminerva Med. 2021 Jun;63(2):199-200. doi: 10.23736/S0031-0808.20.04049-5. Epub 2020 Aug 5.
10
Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis.特发性肺纤维化急性加重的危险因素。
Respir Res. 2016 Jul 11;17(1):79. doi: 10.1186/s12931-016-0400-1.
引用本文的文献
1
Medicinal Plant-Derived Exosome-Like Nanovesicles as Regulatory Mediators in Microenvironment for Disease Treatment.药用植物来源的类外泌体纳米囊泡作为疾病治疗微环境中的调节介质
Int J Nanomedicine. 2025 Jun 30;20:8451-8479. doi: 10.2147/IJN.S526287. eCollection 2025.
2
C-phycocyanin reinforces autophagy to block pulmonary fibrogenesis by inhibiting lncIAPF biogenesis.藻蓝蛋白通过抑制 lncIAPF 的生成来增强自噬以阻断肺纤维化发生。
Arch Pharm Res. 2024 Jul;47(7):659-674. doi: 10.1007/s12272-024-01508-y. Epub 2024 Jul 22.
3
Reply to Cottin , to Johannson , to Scholand and Wells, and to Crowley .回复科廷、约翰松、肖兰德和韦尔斯，以及克劳利。
Am J Respir Crit Care Med. 2023 Jun 1;207(11):1542-1543. doi: 10.1164/rccm.202305-0786LE.
本文引用的文献
1
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化（更新版）和成人进展性肺纤维化：美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
2
Use of a Genomic Classifier in Patients with Interstitial Lung Disease: A Systematic Review and Meta-Analysis.基因组分类器在间质性肺疾病患者中的应用：一项系统评价和荟萃分析。
Ann Am Thorac Soc. 2022 May;19(5):827-832. doi: 10.1513/AnnalsATS.202102-197OC.
3
Bleeding risk of transbronchial cryobiopsy compared to transbronchial forceps biopsy in interstitial lung disease - a prospective, randomized, multicentre cross-over trial.经支气管冷冻活检与经支气管咬检在间质性肺疾病中的出血风险比较：一项前瞻性、随机、多中心交叉试验。
Respir Res. 2019 Jul 5;20(1):140. doi: 10.1186/s12931-019-1091-1.
Zotero 插件